TYVASO

Serial Number 77425786
Registration 3709561
800

Registration Progress

Application Filed
Mar 19, 2008
Under Examination
Sep 16, 2008
Approved for Publication
Jun 4, 2008
Published for Opposition
Jun 24, 2008
Registered
Nov 10, 2009

Basic Information

Serial Number
77425786
Registration Number
3709561
Filing Date
March 19, 2008
Registration Date
November 10, 2009
Published for Opposition
June 24, 2008
Renewal Date
November 10, 2019
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
800
Status Date
Dec 20, 2019
Registration
Registered
Classes
005

Rights Holder

UNITED THERAPEUTICS CORPORATION

03
Address
1110 SPRING STREET
SILVER SPRING, MD 20910

Ownership History

Lung Rx, Inc.

Original Applicant
03
Silver Spring, MD

Lung Rx, Inc.

Owner at Publication
03
Silver Spring, MD

Lung Rx, Inc.

Original Registrant
03
Silver Spring, MD

UNITED THERAPEUTICS CORPORATION

New Owner After Registration #1
03
SILVER SPRING, MD

Legal Representation

Attorney
Norm J. Rich

USPTO Deadlines

Next Deadline
1585 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2009-11-10)
Due Date
November 10, 2029
Grace Period Ends
May 10, 2030

Application History

29 events
Date Code Type Description
Dec 20, 2019 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 20, 2019 89AG O REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Dec 20, 2019 RNL1 Q REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Dec 20, 2019 NA89 E NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Nov 6, 2019 E89R I TEAS SECTION 8 & 9 RECEIVED
Nov 10, 2018 REM2 E COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Jan 12, 2016 C15A O REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 12, 2016 NA85 E NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Jan 8, 2016 APRE A CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Nov 4, 2015 E815 I TEAS SECTION 8 & 15 RECEIVED
Jun 9, 2010 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Nov 10, 2009 R.PR A REGISTERED-PRINCIPAL REGISTER
Oct 8, 2009 REGV O LAW OFFICE REGISTRATION REVIEW COMPLETED
Oct 6, 2009 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Sep 22, 2009 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sep 22, 2009 SUPC I STATEMENT OF USE PROCESSING COMPLETE
Sep 3, 2009 EISU I TEAS STATEMENT OF USE RECEIVED
Sep 3, 2009 IUAF S USE AMENDMENT FILED
Mar 12, 2009 EEXT I SOU TEAS EXTENSION RECEIVED
Mar 12, 2009 EXT1 S SOU EXTENSION 1 FILED
Mar 12, 2009 EX1G S SOU EXTENSION 1 GRANTED
Sep 16, 2008 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT
Jun 24, 2008 PUBO A PUBLISHED FOR OPPOSITION
Jun 4, 2008 NPUB O NOTICE OF PUBLICATION
May 21, 2008 DOCK D ASSIGNED TO EXAMINER
May 21, 2008 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
May 21, 2008 ALIE A ASSIGNED TO LIE
May 21, 2008 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED
Mar 25, 2008 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension
First Use Anywhere: Sep 2, 2009
First Use in Commerce: Sep 2, 2009

Classification

International Classes
005